2-Aminoisonicotinic acid

We are 2-Aminoisonicotinic acid CAS:13362-28-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:   2-Aminoisonicotinic acid
CAS.NO:13362-28-2
Synonyms:   2-Aminoisonicotinic acid
2-Amino-isonicotinic acid
2-aminopyridine-4-carboxylic acid
2-Amino-4-pyridinecarboxylic acid
 
Molecular Formula:C6H6N2O2
Molecular Weight:138.12400
 
Physical and Chemical Properties:
Density:1.417 g/cm3
Boiling point:498.5ºC at 760 mmHg
Melting point:300-302°C
Flash point:/
Index of Refraction:1.649
 
Specification:
Appearance:Light yellow crystal
Purity:≥99.0%
 
Packing:25kg/drum, can also be packaged according to customer requirements
Storage:Preserve in well-closed, light-resistant and airtight containers
Application: Pesticide intermediates, dye intermediates, flavor and fragrance intermediates, pharmaceutical intermediates

2-Aminoisonicotinic acid


Related News: Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.2-Fluoro-6-methylbenzaldehyde CAS:117752-04-2 Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large.4-cloro-3-metilisoxazol-5-amina CAS:166964-09-6 Jo Soden, Co-managing Director of Retrogenix, said “We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant’s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.”24016-03-3 Jo Soden, Co-managing Director of Retrogenix, said “We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant’s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.”Jo Soden, Co-managing Director of Retrogenix, said “We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant’s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.”

Related Products
Product Name
7-bromo-1-heptanol acetate View Details
4-(4-bromophenyl)-N,N-diphenylaniline View Details
N-(3-methyl-2,6-dihydro-1,3,5-oxadiazin-4-yl)nitramide View Details
Exenatide acetate manufacturer 5-Chloro-1,3-xylene manufacturer 5-Bromo-2-fluorobenzoic acid manufacturer 2-Hydroxy-3-methyl-2-cyclopentenone manufacturer 2-Chloro-3-fluoro-5-methylpyridine manufacturer